1. Home
  2. CCLD vs RFL Comparison

CCLD vs RFL Comparison

Compare CCLD & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$2.19

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.57

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCLD
RFL
Founded
1999
2017
Country
United States
United States
Employees
3650
N/A
Industry
Computer Software: Prepackaged Software
Real Estate
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
92.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
CCLD
RFL
Price
$2.19
$2.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
326.9K
230.3K
Earning Date
05-07-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
$11.49
N/A
Revenue Next Year
$7.95
N/A
P/E Ratio
$32.04
N/A
Revenue Growth
N/A
43.96
52 Week Low
$2.09
$1.12
52 Week High
$4.01
$2.80

Technical Indicators

Market Signals
Indicator
CCLD
RFL
Relative Strength Index (RSI) 36.88 75.69
Support Level N/A $1.22
Resistance Level $2.40 N/A
Average True Range (ATR) 0.11 0.26
MACD 0.00 0.11
Stochastic Oscillator 5.26 79.33

Price Performance

Historical Comparison
CCLD
RFL

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: